The normal immune system requires the capacity to regulate T-cell function, in order to resist the effects of pathogens and yet prevent the development of pathological autoimmune responses. Clonal anergy has been proposed as one potential mechanism for this control of immune reactivity in helper T cells. It is defined as a state of T-cell unresponsiveness that prevents their proliferation in response to antigen stimulation. Previous research has suggested that defective IL-2 production underlies this unresponsiveness, and this arises from of a block in signal transduction to the IL-2 gene enhancer. Working back from the nucleus, it has now been shown that: a) trans-activation at the IL-2 enhancer fails, b) AP-1 nuclear complex formation is defective, c) c-fos, fosB and junB expression cannot be induced and d) ERK, JNK and p38 activation are blocked, despite normal protein levels. Thus, a defect in signal transduction up-stream of MAPK activation at the level of coupling between the TCR/CD3 complex and p21 ras appears to be the cause of clonal anergy. Perhaps consistent with this, a heterokaryon analysis has demonstrated the presence of a dominant-acting repressor molecule in anergic T cells. Finally, our work has revealed a role for TCR and CD28 signal integration at the level of the Elk-I transcription factor, and this may prove to be an additional site of regulation by clonal anergy at the c-fos gene. With this new information, this research project will once again target the TCRJp2 1 ras/MAPK/AP- I /IL-2 gene signal transduction pathway for further investigation, and define those biochemical alterations that impair the expression of the IL-2 gene. Specifically, this research will: a) Determine the biochemical, molecular genetic and functional nature of TCR and CD28 signal integration at the level Elk-1/CBP trans-activation in normal and anergic Thl cells and b) Explore the nature of IL-2 gene repression in clonal anergy using a heterokaryon analysis. The information gained in this study will provide a better understanding of the biochemical mechanisms utilized by the immune system to regulate responsiveness to foreign and self-antigens, and may prove essential to the design of effective clinical therapies for infection, cancer and autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM054706-06
Application #
6621934
Study Section
Immunobiology Study Section (IMB)
Program Officer
Marino, Pamela
Project Start
1996-07-01
Project End
2005-12-31
Budget Start
2003-01-01
Budget End
2003-12-31
Support Year
6
Fiscal Year
2003
Total Cost
$297,000
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Agarwal, Pujya; Raghavan, Arvind; Nandiwada, Sarada L et al. (2009) Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 183:1695-704
Zhang, Ruan; Zhang, Na; Mueller, Daniel L (2008) Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion. J Immunol 181:5331-9
Mondino, Anna; Mueller, Daniel L (2007) mTOR at the crossroads of T cell proliferation and tolerance. Semin Immunol 19:162-72
Bonnevier, Jody L; Yarke, Cory A; Mueller, Daniel L (2006) Sustained B7/CD28 interactions and resultant phosphatidylinositol 3-kinase activity maintain G1-->S phase transitions at an optimal rate. Eur J Immunol 36:1583-97
Nandiwada, Sarada L; Li, Wei; Zhang, Ruan et al. (2006) p300/Cyclic AMP-responsive element binding-binding protein mediates transcriptional coactivation by the CD28 T cell costimulatory receptor. J Immunol 177:401-13
Vanasek, Tracy L; Nandiwada, Sarada L; Jenkins, Marc K et al. (2006) CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. J Immunol 176:5880-9
Bonnevier, Jody L; Zhang, Ruan; Mueller, Daniel L (2005) E3 ubiquitin ligases and their control of T cell autoreactivity. Arthritis Res Ther 7:233-42
Mueller, Daniel L (2004) E3 ubiquitin ligases as T cell anergy factors. Nat Immunol 5:883-90
Bonnevier, Jody L; Mueller, Daniel L (2002) Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling. J Immunol 169:6659-63
Li, W; Whaley, C D; Bonnevier, J L et al. (2001) CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation. J Immunol 167:827-35

Showing the most recent 10 out of 13 publications